Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Sep 20 2022

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-sep-20-2022-2

Zydus Lifesciences Limited has informed the Exchange about press release dated 20-Sep-2022 titled BridgeBio Pharma and Sentynl Therapeutics Receive Marketing Authorization in the EU for NULIBRY��

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases